• Home
  • Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

Author List
Fahim SM, Tice JA, Luu L, Carlson JJ, Richardson M, Herce-Hagiwara B, Dickerson R, Ollendorf DA
Publication
Journal of managed care & specialty pharmacy
Publication ID (Profile URL)
https://researcherprofiles.org/profile/565243886
Publication Year
2024
PubMed ID
39612256
Publication Title
Fahim SM, Tice JA, Luu L, Carlson JJ, Richardson M, Herce-Hagiwara B, Dickerson R, Ollendorf DA. Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum. J Manag Care Spec Pharm. 2024 Dec; 30(12):1479-1485.